The importance of N6-methyladenosine modification in tumor immunity and immunotherapy

As the most common and abundant RNA modification in eukaryotic cells, N6-methyladenosine (m6A) modification plays an important role in different stages of tumor. m6A can participate in the regulation of tumor immune escape, so as to enhance the monitoring of tumor by the immune system and reduce tum...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ze, Liu, Furong, Chen, Wei, Liao, Zhibin, Zhang, Wanguang, Zhang, Bixiang, Liang, Huifang, Chu, Liang, Zhang, Zhanguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118853/
https://www.ncbi.nlm.nih.gov/pubmed/35590394
http://dx.doi.org/10.1186/s40164-022-00281-2
Descripción
Sumario:As the most common and abundant RNA modification in eukaryotic cells, N6-methyladenosine (m6A) modification plays an important role in different stages of tumor. m6A can participate in the regulation of tumor immune escape, so as to enhance the monitoring of tumor by the immune system and reduce tumorgenesis. m6A can also affect the tumor progression by regulating the immune cell responses to tumor in tumor microenvironment. In addition, immunotherapy has become the most popular method for the treatment of cancer, in which targets such as immune checkpoints are also closely associated with m6A. This review discusses the roles of N6-methyladenosine modification in tumor immune regulation, their regulatory mechanism, and the prospect of immunotherapy. GRAPHICAL ABSTRACT: [Image: see text]

Ejemplares similares